Ashley Buscetta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ashley Buscetta has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Vence L. Bonham
Social and Behavioral Research Branch, National Human Genome Research Institute , Bethesda, MD 20892
3 shared publications - Adrianna K. San Roman
Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA
2 shared publications - Alexander K. Godfrey
Whitehead Institute
2 shared publications - Angela E. Lin
Medical Genetics, Department of Pediatrics Mass General for Children Boston Massachusetts USA
2 shared publications - David Conrad Page
Whitehead Institute, Cambridge, USA
2 shared publications - Helen Skaletsky
Whitehead Institute
2 shared publications
Latest Publications
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
“I think if we don’t eat well, we will be sicker”: a qualitative perspective on contributing factors to diet intake and nutrition among adults living with SCD in the United States
Objectives: SCD is a monogenic condition with complex pathophysiological pathways influenced by nutrition. While dietary management is recognized in pediatric SCD populations, the role of diet in symptom variability and disease severity among adults living with SCD has not been widely reported nor systematically studied. This study utilizes qualitative data to investigate intrapersonal and environmental facilitators and barriers to dietary intake among adults with SCD. Methods: This cross-sectional, single-site mixed-methods study (NCT05170412) included 47 adults living with SCD from multiple US regions through in-person and telehealth visits. Data collection involved semi-structured interviews, dietary recall surveys, and clinical assessments. Thematic analysis using iterative coding identified key themes related to food choices, symptom management, and social determinants of health. Results: Participants reported that economic constraints, food environment limitations, and acute symptoms disrupted dietary intake. Food insecurity risk was prevalent, with many residing in low-income, low-access areas. Barriers included high costs of nutritious foods and work-related dietary restrictions. Facilitators included social support, cultural food preferences, and access to reliable nutritional information. Participants expressed interest in dietary self-management strategies, but cited limited access to professional dietary guidance. Conclusions: For adults with SCD, diet and nutrition are significantly related to symptoms. Food access, symptom-related dietary interruptions, and cultural preferences shape dietary behaviors. These findings highlight the need for personalized dietary interventions, improved food access, and clinician-guided nutritional education. Addressing these factors could enhance self-management strategies related to diet and overall disease outcomes.
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
“I think if we don’t eat well, we will be sicker”: a qualitative perspective on contributing factors to diet intake and nutrition among adults living with SCD in the United States
Objectives: SCD is a monogenic condition with complex pathophysiological pathways influenced by nutrition. While dietary management is recognized in pediatric SCD populations, the role of diet in symptom variability and disease severity among adults living with SCD has not been widely reported nor systematically studied. This study utilizes qualitative data to investigate intrapersonal and environmental facilitators and barriers to dietary intake among adults with SCD. Methods: This cross-sectional, single-site mixed-methods study (NCT05170412) included 47 adults living with SCD from multiple US regions through in-person and telehealth visits. Data collection involved semi-structured interviews, dietary recall surveys, and clinical assessments. Thematic analysis using iterative coding identified key themes related to food choices, symptom management, and social determinants of health. Results: Participants reported that economic constraints, food environment limitations, and acute symptoms disrupted dietary intake. Food insecurity risk was prevalent, with many residing in low-income, low-access areas. Barriers included high costs of nutritious foods and work-related dietary restrictions. Facilitators included social support, cultural food preferences, and access to reliable nutritional information. Participants expressed interest in dietary self-management strategies, but cited limited access to professional dietary guidance. Conclusions: For adults with SCD, diet and nutrition are significantly related to symptoms. Food access, symptom-related dietary interruptions, and cultural preferences shape dietary behaviors. These findings highlight the need for personalized dietary interventions, improved food access, and clinician-guided nutritional education. Addressing these factors could enhance self-management strategies related to diet and overall disease outcomes.
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1) , yoaf004
The role of religiosity and spirituality in coping with sickle cell disease clinical severity
Objectives: Religiosity and spirituality often play a role in managing chronic diseases. Sickle cell disease (SCD) is a genetic chronic disease associated with lifelong complications, but there is limited analysis of the potential impact of religiosity and spirituality on SCD. This study aims to analyze the association between constructs of religiosity and spirituality with health outcomes (disease severity, depression, and pain) in an SCD population (n = 275). Methods: Data from the INSIGHTS Study (NCT02156102) were used for this analysis. The relationships between religious/spirituality measures (religious attendance, self-reported spirituality, religious saliency, coping, and support) and SCD outcomes (disease severity, depression, and pain scores) were analyzed through bivariate correlations and multivariable models. Models adjusted for different dimensions of religiosity and spirituality separately (Model 1) and all measures simultaneously (Model 2). Results: In the bivariate analyses, we found a positive association between disease severity and spirituality (P < .05) and an inverse relationship between positive religious coping and depression (P = .01). In Model 1, which adjusted for individual measures separately, there was an association between SCD severity and spirituality (β = 0.07, P < .001) as well as with religious attendance (β = 0.02, P < .01). However, in the models that simultaneously adjusted for all the measures (Model 2), religious attendance was no longer associated with SCD severity (β = 0.006, P > .05), while the association with spirituality remained significant (β = 0.05, P < .05). Conclusions: The observed associations between spirituality and disease severity among patients with SCD suggest that individuals with severe disease may beneficially use spirituality to cope with complications. Future research should rigorously evaluate this hypothesis.
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1) , yoaf004
The role of religiosity and spirituality in coping with sickle cell disease clinical severity
Objectives: Religiosity and spirituality often play a role in managing chronic diseases. Sickle cell disease (SCD) is a genetic chronic disease associated with lifelong complications, but there is limited analysis of the potential impact of religiosity and spirituality on SCD. This study aims to analyze the association between constructs of religiosity and spirituality with health outcomes (disease severity, depression, and pain) in an SCD population (n = 275). Methods: Data from the INSIGHTS Study (NCT02156102) were used for this analysis. The relationships between religious/spirituality measures (religious attendance, self-reported spirituality, religious saliency, coping, and support) and SCD outcomes (disease severity, depression, and pain scores) were analyzed through bivariate correlations and multivariable models. Models adjusted for different dimensions of religiosity and spirituality separately (Model 1) and all measures simultaneously (Model 2). Results: In the bivariate analyses, we found a positive association between disease severity and spirituality (P < .05) and an inverse relationship between positive religious coping and depression (P = .01). In Model 1, which adjusted for individual measures separately, there was an association between SCD severity and spirituality (β = 0.07, P < .001) as well as with religious attendance (β = 0.02, P < .01). However, in the models that simultaneously adjusted for all the measures (Model 2), religious attendance was no longer associated with SCD severity (β = 0.006, P > .05), while the association with spirituality remained significant (β = 0.05, P < .05). Conclusions: The observed associations between spirituality and disease severity among patients with SCD suggest that individuals with severe disease may beneficially use spirituality to cope with complications. Future research should rigorously evaluate this hypothesis.
- Open Access
Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell types
Summary: Recent in vitro studies of human sex chromosome aneuploidy showed that the Xi (“inactive” X) and Y chromosomes broadly modulate autosomal and Xa (“active” X) gene expression in two cell types. We tested these findings in vivo in two additional cell types. Using linear modeling in CD4+ T cells and monocytes from individuals with one to three X chromosomes and zero to two Y chromosomes, we identified 82 sex-chromosomal and 344 autosomal genes whose expression changed significantly with Xi and/or Y dosage in vivo . Changes in sex-chromosomal expression were remarkably constant in vivo and in vitro across all four cell types examined. In contrast, autosomal responses to Xi and/or Y dosage were largely cell-type-specific, with up to 2.6-fold more variation than sex-chromosomal responses. Targets of the X- and Y-encoded transcription factors ZFX and ZFY accounted for a significant fraction of these autosomal responses both in vivo and in vitro . We conclude that the human Xi and Y transcriptomes are surprisingly robust and stable across the four cell types examined, yet they modulate autosomal and Xa genes – and cell function – in a cell-type-specific fashion. These emerging principles offer a foundation for exploring the wide-ranging regulatory roles of the sex chromosomes across the human body.
Open AccessStable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell types
Summary: Recent in vitro studies of human sex chromosome aneuploidy showed that the Xi (“inactive” X) and Y chromosomes broadly modulate autosomal and Xa (“active” X) gene expression in two cell types. We tested these findings in vivo in two additional cell types. Using linear modeling in CD4+ T cells and monocytes from individuals with one to three X chromosomes and zero to two Y chromosomes, we identified 82 sex-chromosomal and 344 autosomal genes whose expression changed significantly with Xi and/or Y dosage in vivo . Changes in sex-chromosomal expression were remarkably constant in vivo and in vitro across all four cell types examined. In contrast, autosomal responses to Xi and/or Y dosage were largely cell-type-specific, with up to 2.6-fold more variation than sex-chromosomal responses. Targets of the X- and Y-encoded transcription factors ZFX and ZFY accounted for a significant fraction of these autosomal responses both in vivo and in vitro . We conclude that the human Xi and Y transcriptomes are surprisingly robust and stable across the four cell types examined, yet they modulate autosomal and Xa genes – and cell function – in a cell-type-specific fashion. These emerging principles offer a foundation for exploring the wide-ranging regulatory roles of the sex chromosomes across the human body.
- Open Access
The human Y and inactive X chromosomes similarly modulate autosomal gene expression
SUMMARY: Somatic cells of human males and females have 45 chromosomes in common, including the “active” X chromosome. In males the 46 th chromosome is a Y; in females it is an “inactive” X (Xi). Through linear modeling of autosomal gene expression in cells from individuals with zero to three Xi and zero to four Y chromosomes, we found that Xi and Y impact autosomal expression broadly and with remarkably similar effects. Studying sex-chromosome structural anomalies, promoters of Xi- and Y-responsive genes, and CRISPR inhibition, we traced part of this shared effect to homologous transcription factors – ZFX and ZFY – encoded by Chr X and Y. This demonstrates sex-shared mechanisms by which Xi and Y modulate autosomal expression. Combined with earlier analyses of sex-linked gene expression, our studies show that 21% of all genes expressed in lymphoblastoid cells or fibroblasts change expression significantly in response to Xi or Y chromosomes.
Open AccessThe human Y and inactive X chromosomes similarly modulate autosomal gene expression
SUMMARY: Somatic cells of human males and females have 45 chromosomes in common, including the “active” X chromosome. In males the 46 th chromosome is a Y; in females it is an “inactive” X (Xi). Through linear modeling of autosomal gene expression in cells from individuals with zero to three Xi and zero to four Y chromosomes, we found that Xi and Y impact autosomal expression broadly and with remarkably similar effects. Studying sex-chromosome structural anomalies, promoters of Xi- and Y-responsive genes, and CRISPR inhibition, we traced part of this shared effect to homologous transcription factors – ZFX and ZFY – encoded by Chr X and Y. This demonstrates sex-shared mechanisms by which Xi and Y modulate autosomal expression. Combined with earlier analyses of sex-linked gene expression, our studies show that 21% of all genes expressed in lymphoblastoid cells or fibroblasts change expression significantly in response to Xi or Y chromosomes.
- Open Access
- 13 November 2019
- Published by American Society of Hematology in Blood
- Vol. 134 (Supplement) , 1025
Clinical Implications of Active Coping on Sleep: John Henryism in a Sickle Cell Disease Cohort
Background: Approximately 57% of individuals with Sickle Cell Disease (SCD) suffer from sleep disorders and poor sleep quality. Poor sleep quality may cause excessive daytime sleepiness and is often associated with psychosocial and clinical factors contributing to disease burden and stress levels. One of these psychosocial factors is John Henryism (JH). Defined as a high-effort, active coping style, JH is used by persons with a strong determination to succeed in the face of chronic stressors. Both sleep and JH have mostly been shown to be negatively associated with cardiovascular health. Living with SCD is a unique stressor and how persons cope with their disease may impact their quality of life and health outcomes. The objective of this study is to 1) evaluate the impact of sleep quality and 2) quantify the effect of sleep quality on high-effort coping among persons with SCD. Methods: The sample comprised 191 adults aged 19-71 with SCD. Most participants were women (57%) and had a mean age of 39 years (SD+12.2) (see Table 1). All participants were enrolled in the Insights into Microbiome and Environmental Contributions to SCD and Leg Ulcers (INSIGHTS) study (NCT02156102). All participants were administered a variety of psychosocial measures, a comprehensive medical history and physical exam, and provided blood and saliva samples for clinical and research analysis. Our binary outcome assessed participants' high or low utilization of JH coping style by using the John Henryism Active Coping Scale (JHAC12). JHAC12 scores were measured from participant responses to a 12-item Likert scale. Scores range from 12 to 60 with higher scores indicting higher utilization of JH active coping. Based on the median JH score of our participants, scores between 12-50.9 were categorized as low utilization of JH and scores between 51-60 were categorized as high utilization of JH. Predictors included demographic data and psychosocial measures. Sleep quality was assessed via clinical and survey measures. Clinically, obstructive sleep apnea was self-reported during a comprehensive medical exam. The ASCQ-ME sleep survey is a 5-item measure, and was used to ascertain participant sleep patterns within the past seven days. Scores range from 40 to 60. Scores less than 50 are considered abnormal. Multivariable logistic regression was performed to evaluate differences within the cohort. Results: Mean ASCQ-ME sleep score of the entire cohort was 46, indicating worse sleep quality for participants compared to the ASCQ-ME national SCD reference cohort. Obstructive sleep-apnea was self-reported by 23 participants (12%). The mean JH score was 52, indicating high utilization of active coping. Poorer sleep quality was associated with higher JH coping (OR:1.14, 95% CI: [1.06-1.22]) (see Table 2). There were no significant associations between utilization of JH active coping with the demographic data including sex, age, education and marital status. Worse sleep quality within the SCD cohort was associated with increased usage of hydroxyurea (r= .16, p<.05), history of cardiovascular disease (r= .13, p<.05), higher pain score at study visit (r=.15, p<.05) and increased systolic blood pressure (r=.18, p<.01). Conclusion: Preliminary findings support a relationship between JH and sleep quality in a SCD cohort. In a disease population with high sleep apnea prevalence, these findings have potential clinical implications. Future work should focus on how these psychosocial factors impact sleep and clinical presentation. Disclosures: Minniti: Doris Duke Foundation: Research Funding.
- 13 November 2019
- Published by American Society of Hematology in Blood
- Vol. 134 (Supplement) , 1025
Open AccessClinical Implications of Active Coping on Sleep: John Henryism in a Sickle Cell Disease Cohort
Background: Approximately 57% of individuals with Sickle Cell Disease (SCD) suffer from sleep disorders and poor sleep quality. Poor sleep quality may cause excessive daytime sleepiness and is often associated with psychosocial and clinical factors contributing to disease burden and stress levels. One of these psychosocial factors is John Henryism (JH). Defined as a high-effort, active coping style, JH is used by persons with a strong determination to succeed in the face of chronic stressors. Both sleep and JH have mostly been shown to be negatively associated with cardiovascular health. Living with SCD is a unique stressor and how persons cope with their disease may impact their quality of life and health outcomes. The objective of this study is to 1) evaluate the impact of sleep quality and 2) quantify the effect of sleep quality on high-effort coping among persons with SCD. Methods: The sample comprised 191 adults aged 19-71 with SCD. Most participants were women (57%) and had a mean age of 39 years (SD+12.2) (see Table 1). All participants were enrolled in the Insights into Microbiome and Environmental Contributions to SCD and Leg Ulcers (INSIGHTS) study (NCT02156102). All participants were administered a variety of psychosocial measures, a comprehensive medical history and physical exam, and provided blood and saliva samples for clinical and research analysis. Our binary outcome assessed participants' high or low utilization of JH coping style by using the John Henryism Active Coping Scale (JHAC12). JHAC12 scores were measured from participant responses to a 12-item Likert scale. Scores range from 12 to 60 with higher scores indicting higher utilization of JH active coping. Based on the median JH score of our participants, scores between 12-50.9 were categorized as low utilization of JH and scores between 51-60 were categorized as high utilization of JH. Predictors included demographic data and psychosocial measures. Sleep quality was assessed via clinical and survey measures. Clinically, obstructive sleep apnea was self-reported during a comprehensive medical exam. The ASCQ-ME sleep survey is a 5-item measure, and was used to ascertain participant sleep patterns within the past seven days. Scores range from 40 to 60. Scores less than 50 are considered abnormal. Multivariable logistic regression was performed to evaluate differences within the cohort. Results: Mean ASCQ-ME sleep score of the entire cohort was 46, indicating worse sleep quality for participants compared to the ASCQ-ME national SCD reference cohort. Obstructive sleep-apnea was self-reported by 23 participants (12%). The mean JH score was 52, indicating high utilization of active coping. Poorer sleep quality was associated with higher JH coping (OR:1.14, 95% CI: [1.06-1.22]) (see Table 2). There were no significant associations between utilization of JH active coping with the demographic data including sex, age, education and marital status. Worse sleep quality within the SCD cohort was associated with increased usage of hydroxyurea (r= .16, p<.05), history of cardiovascular disease (r= .13, p<.05), higher pain score at study visit (r=.15, p<.05) and increased systolic blood pressure (r=.18, p<.01). Conclusion: Preliminary findings support a relationship between JH and sleep quality in a SCD cohort. In a disease population with high sleep apnea prevalence, these findings have potential clinical implications. Future work should focus on how these psychosocial factors impact sleep and clinical presentation. Disclosures: Minniti: Doris Duke Foundation: Research Funding.